Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OGI 
OrganiGram Holdings Inc (OGI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: OGI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8.8
1 Year Target Price $8.8
| 3 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -29.39% | Avg. Invested days 29 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 264.19M USD | Price to earnings Ratio 196 | 1Y Target Price 8.8 |
Price to earnings Ratio 196 | 1Y Target Price 8.8 | ||
Volume (30-day avg) 4 | Beta 2.09 | 52 Weeks Range 0.85 - 2.08 | Updated Date 10/15/2025 |
52 Weeks Range 0.85 - 2.08 | Updated Date 10/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.01 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.47% | Operating Margin (TTM) -2.97% |
Management Effectiveness
Return on Assets (TTM) -5.56% | Return on Equity (TTM) -54.53% |
Valuation
Trailing PE 196 | Forward PE 153.85 | Enterprise Value 230137506 | Price to Sales(TTM) 1.18 |
Enterprise Value 230137506 | Price to Sales(TTM) 1.18 | ||
Enterprise Value to Revenue 1.43 | Enterprise Value to EBITDA 9.27 | Shares Outstanding 134022167 | Shares Floating 93831789 |
Shares Outstanding 134022167 | Shares Floating 93831789 | ||
Percent Insiders 32.31 | Percent Institutions 6.05 |
Upturn AI SWOT
OrganiGram Holdings Inc
Company Overview
History and Background
OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, New Brunswick, Canada. It began as a medical cannabis producer and has since expanded into the recreational market. Key milestones include securing Health Canada licenses and expanding production capacity.
Core Business Areas
- Cannabis Cultivation and Production: Cultivation, processing, and packaging of cannabis products, including dried flower, edibles, extracts, and concentrates.
- Product Innovation: Development of new cannabis products and formulations.
- Sales and Distribution: Selling and distributing cannabis products to retailers and consumers.
Leadership and Structure
The company is led by a board of directors and a management team, with key figures like the CEO and CFO. The organizational structure includes departments for cultivation, production, sales, marketing, and finance.
Top Products and Market Share
Key Offerings
- Dried Flower: Traditional dried cannabis flower, a core product offering. Market share varies by region, but faces competition from numerous producers. Competitors include Canopy Growth, Aurora Cannabis, and Tilray.
- Edibles: Cannabis-infused gummies and chocolates. Market share is growing, especially in recreational markets. Competitors include Wana Brands and Bhang.
- Vapes: Cannabis vape pens and cartridges. Market share fluctuates with changing regulations and consumer preferences. Competitors include PAX and Select.
Market Dynamics
Industry Overview
The cannabis industry is rapidly evolving, with increasing legalization and growing consumer acceptance. It is characterized by intense competition, regulatory changes, and fluctuating prices.
Positioning
OrganiGram focuses on producing high-quality cannabis and innovative products. Its competitive advantage lies in its unique cultivation methods and efficient production facilities. Market share lags behind industry leaders.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions USD. OrganiGram is positioned to capture a fraction of this TAM, focusing on specific product categories and geographic regions.
Upturn SWOT Analysis
Strengths
- Innovative cultivation techniques
- Strategic partnerships
- Strong brand reputation
- Expanding product portfolio
Weaknesses
- Limited market share compared to industry leaders
- Dependence on regulatory approvals
- Price competition in the market
- Geographic concentration
Opportunities
- Expanding into new geographic markets
- Developing new cannabis products
- Increasing legalization and acceptance of cannabis
- Partnerships and acquisitions
Threats
- Intense competition
- Regulatory changes
- Fluctuating cannabis prices
- Economic downturn
Competitors and Market Share
Key Competitors
- TLRY
- CGC
- ACB
Competitive Landscape
OrganiGram faces intense competition. Advantages include production innovation. Disadvantages include market share deficit against peers.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been characterized by periods of rapid expansion followed by consolidation.
Future Projections: Future growth is projected to be driven by new product launches, geographic expansion, and increasing legalization.
Recent Initiatives: Recent initiatives include investments in production capacity, new product development, and strategic partnerships.
Summary
OrganiGram is a cannabis company with a focus on product innovation. Its cultivation techniques give it an edge in production, but it lags behind industry leaders in market share. Future growth depends on navigating regulatory changes, expanding into new markets, and executing its strategic initiatives. OrganiGram needs to strengthen its distribution network and focus on brand building to improve sales.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Financial News Outlets
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Market conditions and company performance can change rapidly. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OrganiGram Holdings Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2014-08-27 | CEO - | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 1178 | Website https://www.organigram.ca |
Full time employees 1178 | Website https://www.organigram.ca | ||
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.